Cerevance Stock
A developer of innovative therapeutics for central nervous system diseases, using technology to identify transcriptional and epigenetic differences between cell types in mature human brains, helping healthcare providers detect and address early neurological conditions.
Founded: 2016
For more Cerevance stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Craig Thompson Chief Executive Officer |
| Mark Carlton, PhD Chief Scientific Officer |
| Sagar Vaidya, MD, PhD Chief Medical Officer |
| Rob Middlebrook Chief Financial Officer |
